Carrick Therapeutics, the Dublin-headquartered drug company launched last week, said it hopes to have its compounds for cancer treatments undergoing clinical trial in a year.
Co-founder Elaine Sullivan told The Sunday Business Post that the company was currently working with scientists on programmes to target three areas – using “molecular pathways” – to fight some of the most aggressive forms of cancer.
“We want to create a multi-portfolio [drug] company and we identified...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Get a Business Account for you and your team